Skip to content

Released Feb 24, 2017, after the close

10-K filed Feb 24, 2017, 55 days after period end · 0001493152-17-001890

Q4 2016 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$767.00Kderived−90.6% vs Q4 2015−45.3% vs Q3 2016
Net Income-$572.00KderivedN/M vs Q4 2015N/M vs Q3 2016
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$487,000−89.8%
Operating Incomederived$761,000N/M
Operating Cash Flowderived$398,000N/M
Free Cash Flowderived$166,000N/M
Margins · derived
Gross margin63.5%+4.8 pt vs Q4 2015
Operating margin99.2%+114.4 pt vs Q4 2015
Net margin-74.6%−59.2 pt vs Q4 2015

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2016derived from reported figuresQ4 2015Q4 2014Q4 2013
Revenue$767.00K$8.16M$8.97M$9.60M
Net Income-$572.00K-$1.26M-$676.00K$597.00K
EPS Diluted—-$0.07-$0.05$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR